Non-Nicotine Agents for Smoking Cessation

Completed · Phase 3

Conditions studied: Tobacco Use Disorder

In brief

The primary objective of this study is to determine which is the better approach to smoking cessation in veterans: bupropion combined with transdermal nicotine or high dose nicotine replacement therapy (NRT) using transdermal nicotine combined with nicotine inhaler.

Key facts

Study ID

NCT00108537

Run by

US Department of Veterans Affairs

Starts

2003-10-01

Expected to finish

2005-09-01

Last updated by the study team

2008-04-04

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Readiness to set a quit date in the next two weeks,
• Current smoking of at least 15 cigarettes a day

You may not qualify if…

• Current untreated depression or receiving treatment for depression,
• History of seizures, major head injury, or other predisposition for seizures

Where it is running

• Denver VA Medical Center — Denver, Colorado, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.